Resultados de procura - Toni M. Brand

  • Mostrando 1 - 14 Resultados de 14
Limitar resultados
  1. 1
    Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab

    Molecular mechanisms of resistance to the EGFR monoclonal antibody cetuximab por Toni M. Brand, Mari Iida, Deric L. Wheeler

    Publicado 2011
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor

    Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor por Mari Iida, Toni M. Brand, David A. Campbell, C Li, Deric L. Wheeler

    Publicado 2012
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  3. 3
    Nuclear EGFR as a molecular target in cancer

    Nuclear EGFR as a molecular target in cancer por Toni M. Brand, Mari Iida, Neha Luthar, Megan M. Starr, Evan J Huppert, Deric L. Wheeler

    Publicado 2013
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  4. 4
    BET Inhibition Overcomes Receptor Tyrosine Kinase–Mediated Cetuximab Resistance in HNSCC

    BET Inhibition Overcomes Receptor Tyrosine Kinase–Mediated Cetuximab Resistance in HNSCC por Brandon Leonard, Toni M. Brand, Rachel A. O’Keefe, Eliot D. Lee, Yan Zeng, Jacquelyn D. Kemmer, Hua Li, Jennifer R. Grandis, Neil E. Bhola

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Sym004, a Novel EGFR Antibody Mixture, Can Overcome Acquired Resistance to Cetuximab

    Sym004, a Novel EGFR Antibody Mixture, Can Overcome Acquired Resistance to Cetuximab por Mari Iida, Toni M. Brand, Megan M. Starr, Chunrong Li, Evan J Huppert, Neha Luthar, Mikkel W. Pedersen, Ivan D. Horak, Michael Kragh, Deric L. Wheeler

    Publicado 2013
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy

    Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy por Mari Iida, Toni M. Brand, Megan M. Starr, Evan J Huppert, Neha Luthar, Harsh Bahrar, John P. Coan, Hannah E. Pearson, Ravi Salgia, Deric L. Wheeler

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-Negative Breast Cancer

    Nuclear Epidermal Growth Factor Receptor Is a Functional Molecular Target in Triple-Negative Breast Cancer por Toni M. Brand, Mari Iida, Emily Dunn, Neha Luthar, Kellie T. Kostopoulos, Kelsey L. Corrigan, Matthew J. Wleklinski, David T. Yang, Kari B. Wisinski, Ravi Salgia, Deric L. Wheeler

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    AXL Mediates Resistance to Cetuximab Therapy

    AXL Mediates Resistance to Cetuximab Therapy por Toni M. Brand, Mari Iida, Andrew P. Stein, Kelsey L. Corrigan, Cara M. Braverman, Neha Luthar, Mahmoud Toulany, Parkash S. Gill, Ravi Salgia, Randall J. Kimple, Deric L. Wheeler

    Publicado 2014
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    RETRACTED: The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor

    RETRACTED: The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor por Toni M. Brand, Mari Iida, Kelsey L. Corrigan, Cara M. Braverman, John P. Coan, Bailey G. Flanigan, Andrew P. Stein, Ravi Salgia, Jana Rolff, Randall J. Kimple, Deric L. Wheeler

    Publicado 2017
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer

    Nuclear EGFR protein expression predicts poor survival in early stage non-small cell lung cancer por Anne M. Traynor, Tracey L. Weigel, Kurt R. Oettel, David T. Yang, Chong Zhang, KyungMann Kim, Ravi Salgia, Mari Iida, Toni M. Brand, Tien Hoang, Toby C. Campbell, Hilary R. Hernan, Deric L. Wheeler

    Publicado 2013
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV+ Patients

    Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV+ Patients por Toni M. Brand, Stefan Hartmann, Neil E. Bhola, Noah D. Peyser, Hua Li, Yan Zeng, Erin Isaacson Wechsler, Max V. Ranall, Sourav Bandyopadhyay, Umamaheswar Duvvuri, Theresa LaVallee, Richard C. Jordan, Daniel E. Johnson, Jennifer R. Grandis

    Publicado 2016
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Multiple Routes to Oncogenesis Are Promoted by the Human Papillomavirus–Host Protein Network

    Multiple Routes to Oncogenesis Are Promoted by the Human Papillomavirus–Host Protein Network por Manon Eckhardt, Wei Zhang, Andrew M. Gross, John Von Dollen, Jeffrey R. Johnson, Kathleen E. Franks-Skiba, Danielle L. Swaney, Tasha L. Johnson, Gwendolyn Μ. Jang, Priya S. Shah, Toni M. Brand, Jacques Archambault, Jason F. Kreisberg, Jennifer R. Grandis, Trey Ideker, Nevan J. Krogan

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma

    AXL Is a Logical Molecular Target in Head and Neck Squamous Cell Carcinoma por Toni M. Brand, Mari Iida, Andrew P. Stein, Kelsey L. Corrigan, Cara M. Braverman, John P. Coan, Hannah E. Pearson, Harsh Bahrar, Tyler L. Fowler, Bryan Bednarz, Sandeep Saha, David T. Yang, Parkash S. Gill, Mark W. Lingen, Vassiliki Saloura, Victoria Villaflor, Ravi Salgia, Randall J. Kimple, Deric L. Wheeler

    Publicado 2015
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for <i>PIK3CA</i>-altered head and neck cancer

    Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for <i>PIK3CA</i>-altered head and neck cancer por Matthew L. Hedberg, Noah D. Peyser, Julie E. Bauman, William E. Gooding, Hua Li, Neil E. Bhola, Tian Ran Zhu, Yan Zeng, Toni M. Brand, Mi‐Ok Kim, Richard C. Jordan, Scott R. VandenBerg, Victor Olivas, Trever G. Bivona, Simion I. Chiosea, Lin Wang, Gordon B. Mills, Jonas T. Johnson, Umamaheswar Duvvuri, Robert L. Ferris, Patrick K. Ha, Daniel E. Johnson, Jennifer R. Grandis

    Publicado 2019
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: